Emmanouil V Dermitzakis

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 35

Top Topics

Systematic Review

Acute Respiratory Distress Syndrome

Psychometric Properties

Top Venues

Journal of clinical medicine

Medicina (Kaunas, Lithuania)

Neurology international

This page only lists publications with an associated author ORCID identifier.

Publications

Emmanouil V Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, Haralabos P Kalofonos
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine. Journal of clinical medicine 13 (2) (2024)
Emmanouil V Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, Haralabos P Kalofonos
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine. Journal of clinical medicine 13 (2) (2024)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine. Toxins 16 (2) (2024)
Dimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, Panagiotis Soldatos, Dimitrios Rallis, Jobst Rudolf, Anna P Andreou, Haralabos P Kalofonos
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review. Journal of clinical medicine 13 (7) (2024)
Dimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, Panagiotis Soldatos, Dimitrios Rallis, Jobst Rudolf, Anna P Andreou, Haralabos P Kalofonos
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review. Journal of clinical medicine 13 (7) (2024)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine. Toxins 16 (2) (2024)
Emmanouil V Dermitzakis, Haralabos P Kalofonos, Konstantinos Bilias, Evangelia Barmpa, Sofia Liapi, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Michail Vikelis
Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options. Journal of clinical medicine 13 (10) (2024)
Emmanouil V Dermitzakis, Haralabos P Kalofonos, Konstantinos Bilias, Evangelia Barmpa, Sofia Liapi, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Michail Vikelis
Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options. Journal of clinical medicine 13 (10) (2024)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine. Toxins 16 (2) (2024)
Dimitrios Rikos, Michail Vikelis, Emmanouil V Dermitzakis, Panagiotis Soldatos, Dimitrios Rallis, Jobst Rudolf, Anna P Andreou, Haralabos P Kalofonos
Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review. Journal of clinical medicine 13 (7) (2024)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine. Toxins 16 (2) (2024)
Michail Vikelis, Haralabos P Kalofonos, Anastasia Antoniou, Konstantinos C Spingos, Athanasios E Skliros, Konstantinos Bilias, Aikaterini Kouroudi, Emmanouil V Dermitzakis, Efstathios A Skliros
A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases. Medicina (Kaunas, Lithuania) 59 (4) (2023)
Michail Vikelis, Haralabos P Kalofonos, Anastasia Antoniou, Konstantinos C Spingos, Athanasios E Skliros, Konstantinos Bilias, Aikaterini Kouroudi, Emmanouil V Dermitzakis, Efstathios A Skliros
A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases. Medicina (Kaunas, Lithuania) 59 (4) (2023)
Maria Papasavva, Michail Vikelis, Vasileios Siokas, Martha-Spyridoula Katsarou, Emmanouil V Dermitzakis, Athanasios Raptis, Efthimios Dardiotis, Nikolaos Drakoulis
Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study. Neurology international 15 (3) (2023)
Michail Vikelis, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, Haralabos P Kalofonos
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of clinical medicine 12 (13) (2023)
Michail Vikelis, Haralabos P Kalofonos, Anastasia Antoniou, Konstantinos C Spingos, Athanasios E Skliros, Konstantinos Bilias, Aikaterini Kouroudi, Emmanouil V Dermitzakis, Efstathios A Skliros
A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases. Medicina (Kaunas, Lithuania) 59 (4) (2023)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of clinical medicine 12 (9) (2023)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry. Journal of clinical medicine 12 (9) (2023)
Georgia Xiromerisiou, Ioannis Ch Lampropoulos, Emmanouil V Dermitzakis, Michail Vikelis, Chrysoula Marogianni, Dimitrios S Mysiris, Haralabos P Kalofonos
Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up. Toxins 15 (9) (2023)
Michail Vikelis, Haralabos P Kalofonos, Anastasia Antoniou, Konstantinos C Spingos, Athanasios E Skliros, Konstantinos Bilias, Aikaterini Kouroudi, Emmanouil V Dermitzakis, Efstathios A Skliros
A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases. Medicina (Kaunas, Lithuania) 59 (4) (2023)
Emmanouil V Dermitzakis, Aikaterini Kouroudi, Haralabos P Kalofonos, Konstantinos C Spingos, Konstantinos Bilias, Michail Vikelis
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Michail Vikelis
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14 (12) (2022)
Emmanouil V Dermitzakis, Aikaterini Kouroudi, Haralabos P Kalofonos, Konstantinos C Spingos, Konstantinos Bilias, Michail Vikelis
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Michail Vikelis
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14 (12) (2022)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Michail Vikelis
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14 (12) (2022)
Emmanouil V Dermitzakis, Aikaterini Kouroudi, Haralabos P Kalofonos, Konstantinos C Spingos, Konstantinos Bilias, Michail Vikelis
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Emmanouil V Dermitzakis, Aikaterini Kouroudi, Haralabos P Kalofonos, Konstantinos C Spingos, Konstantinos Bilias, Michail Vikelis
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Michail Vikelis
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14 (12) (2022)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Michail Vikelis
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14 (12) (2022)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Michail Vikelis
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14 (12) (2022)
Haralabos P Kalofonos, Emmanouil V Dermitzakis, Georgia Xiromerisiou, Michail Vikelis
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14 (12) (2022)
Emmanouil V Dermitzakis, Michail Vikelis, George S Vlachos, Haralabos P Kalofonos
Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis. Toxins 14 (5) (2022)
Emmanouil V Dermitzakis, Michail Vikelis, George S Vlachos, Haralabos P Kalofonos
Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine. Toxins 14 (7) (2022)
Emmanouil V Dermitzakis, Aikaterini Kouroudi, Haralabos P Kalofonos, Konstantinos C Spingos, Konstantinos Bilias, Michail Vikelis
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction. Medicina (Kaunas, Lithuania) 59 (1) (2022)
Michail Vikelis, Emmanouil V Dermitzakis, George S Vlachos, Panagiotis Soldatos, Konstantinos C Spingos, Pantelis Litsardopoulos, Evangelia Kararizou, Haralabos P Kalofonos
Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis. Journal of clinical medicine 10 (1) (2020)